AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 1,295.53 | 1,002.97 | 805.60 | 813.56 | 831.81 |
| Expenses | |||||
| Material consumed | 596.77 | 362.42 | 315.07 | 297.98 | 307.86 |
| Manufacturing expenses | 4.87 | 5.54 | 8.10 | 7.37 | 7.72 |
| Personnel expenses | 241.45 | 259.10 | 230.21 | 219.54 | 216.70 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 267.99 | 210.79 | 166.04 | 153.20 | 178.83 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 1,111.08 | 837.85 | 719.42 | 678.09 | 711.11 |
| Operating profit | 184.45 | 165.12 | 86.18 | 135.47 | 120.70 |
| Other recurring income | 34.80 | 26.10 | 14.76 | 12.84 | 12.99 |
| Adjusted PBDIT | 219.25 | 191.22 | 100.94 | 148.31 | 133.69 |
| Financial expenses | 1.20 | 0.63 | 0.95 | 1.09 | 1.14 |
| Depreciation | 14.94 | 16.26 | 16.95 | 20.13 | 18.58 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 203.11 | 174.33 | 83.04 | 127.09 | 113.97 |
| Tax charges | 58.03 | 34.81 | 21.44 | 33.79 | 41.76 |
| Adjusted PAT | 145.08 | 139.52 | 61.60 | 93.30 | 72.21 |
| Non recurring items | 17.43 | -42.84 | -1.74 | 3.43 | -4.92 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 162.51 | 96.68 | 59.86 | 96.73 | 67.29 |
| Earnigs before appropriation | 618.15 | 475.64 | 383.96 | 329.10 | 235.38 |
| Equity dividend | 40.00 | 20.00 | 5.00 | 5.00 | 1.99 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | 0.51 |
| Retained earnings | 578.15 | 455.64 | 378.96 | 324.10 | 232.88 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis